PyInvesting

Market research

7733.TSE Olympus Corporation

TSE JPY Healthcare

Latest close

1,848.50 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
2T
P/E ratio
28.98
Analyst target
2084.6155
Dividend yield
1.7%
Beta
0.27

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Olympus Corporation is currently in a long term downtrend where the price is trading 1.2% below its 200 day moving average.

From a valuation standpoint, the stock is 94.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.8.

Olympus Corporation's total revenue sank by 4.3% to $197B since the same quarter in the previous year.

Its net income has increased by 5.4% to $24B since the same quarter in the previous year.

Finally, its free cash flow grew by 78.1% to $42B since the same quarter in the previous year.

Based on the above factors, Olympus Corporation gets an overall score of 3/5.